Tadeja Režen

1.4k total citations · 1 hit paper
43 papers, 962 citations indexed

About

Tadeja Režen is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Tadeja Režen has authored 43 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Surgery and 9 papers in Cancer Research. Recurrent topics in Tadeja Režen's work include Cholesterol and Lipid Metabolism (14 papers), Pharmacogenetics and Drug Metabolism (5 papers) and MicroRNA in disease regulation (4 papers). Tadeja Režen is often cited by papers focused on Cholesterol and Lipid Metabolism (14 papers), Pharmacogenetics and Drug Metabolism (5 papers) and MicroRNA in disease regulation (4 papers). Tadeja Režen collaborates with scholars based in Slovenia, France and United States. Tadeja Režen's co-authors include Damjana Rozman, Edit Mikó, Patrik Kovács, Péter Bai, Adrienn Sipos, Tündé Kovàcs, Anja Kovanda, Boris Rogelj, Peter Juvan and Katalin Monostory and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Tadeja Režen

39 papers receiving 950 citations

Hit Papers

The role of bile acids in... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tadeja Režen Slovenia 16 431 204 180 150 134 43 962
Jay V. Patankar Austria 18 513 1.2× 280 1.4× 108 0.6× 198 1.3× 181 1.4× 35 1.1k
Xiaobing Cui China 17 525 1.2× 217 1.1× 256 1.4× 130 0.9× 122 0.9× 42 1.0k
Ruizhi Tan China 21 716 1.7× 132 0.6× 179 1.0× 89 0.6× 133 1.0× 73 1.4k
Chao Guo China 19 520 1.2× 85 0.4× 196 1.1× 120 0.8× 147 1.1× 53 1.1k
Yuhong Luo China 16 697 1.6× 107 0.5× 266 1.5× 170 1.1× 195 1.5× 39 1.2k
Xuemei Gu China 17 390 0.9× 178 0.9× 69 0.4× 98 0.7× 236 1.8× 40 1.0k
Kaili Fu China 12 573 1.3× 145 0.7× 138 0.8× 181 1.2× 461 3.4× 14 1.1k
Weixing Chen China 22 440 1.0× 241 1.2× 128 0.7× 219 1.5× 216 1.6× 58 1.3k
Mohammad Zahid Ashraf India 22 546 1.3× 188 0.9× 193 1.1× 57 0.4× 105 0.8× 50 1.4k

Countries citing papers authored by Tadeja Režen

Since Specialization
Citations

This map shows the geographic impact of Tadeja Režen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadeja Režen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadeja Režen more than expected).

Fields of papers citing papers by Tadeja Režen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadeja Režen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadeja Režen. The network helps show where Tadeja Režen may publish in the future.

Co-authorship network of co-authors of Tadeja Režen

This figure shows the co-authorship network connecting the top 25 collaborators of Tadeja Režen. A scholar is included among the top collaborators of Tadeja Režen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadeja Režen. Tadeja Režen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Režen, Tadeja, et al.. (2025). The importance of sex dimorphism in liver metabolism and progressive liver diseases. Biology of Sex Differences. 17(1). 14–14.
4.
Moškon, Miha & Tadeja Režen. (2023). Context-Specific Genome-Scale Metabolic Modelling and Its Application to the Analysis of COVID-19 Metabolic Signatures. Metabolites. 13(1). 126–126. 13 indexed citations
5.
Moškon, Miha, et al.. (2022). Integrative Analysis of Rhythmicity: From Biology to Urban Environments and Sustainability. International Journal of Environmental Research and Public Health. 20(1). 764–764.
7.
Režen, Tadeja, Damjana Rozman, Tündé Kovàcs, et al.. (2022). The role of bile acids in carcinogenesis. Cellular and Molecular Life Sciences. 79(5). 182 indexed citations breakdown →
8.
Vidmar, Robert, et al.. (2022). Circular RNA hsa_circ_0062682 Binds to YBX1 and Promotes Oncogenesis in Hepatocellular Carcinoma. Cancers. 14(18). 4524–4524. 12 indexed citations
9.
Jones, M., Tadeja Režen, Mèlika Ben Ahmed, et al.. (2022). Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma. Scientific Reports. 12(1). 13854–13854. 1 indexed citations
10.
Barlič‐Maganja, Darja, et al.. (2022). Whole transcriptome expression array analysis of human colon fibroblasts culture treated with Helichrysum italicum supports its use in traditional medicine. Journal of Ethnopharmacology. 296. 115505–115505. 3 indexed citations
11.
Režen, Tadeja, Tanja Kunej, Martina Fink, et al.. (2021). Genetic analysis of 39 erythrocytosis and hereditary hemochromatosis‐associated genes in the Slovenian family with idiopathic erythrocytosis. Journal of Clinical Laboratory Analysis. 35(4). e23715–e23715. 8 indexed citations
12.
Rozman, Damjana, et al.. (2021). Guided extraction of genome-scale metabolic models for the integration and analysis of omics data. Computational and Structural Biotechnology Journal. 19. 3521–3530. 18 indexed citations
13.
Režen, Tadeja, et al.. (2020). Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1866(2). 158849–158849. 109 indexed citations
14.
Giacca, Mauro, et al.. (2020). VLDL and HDL attenuate endoplasmic reticulum and metabolic stress in HL-1 cardiomyocytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(8). 158713–158713. 2 indexed citations
15.
Režen, Tadeja, et al.. (2019). Factors affecting RNA quantification from tissue long-term stored in formalin. Journal of Pharmacological and Toxicological Methods. 96. 61–66. 3 indexed citations
16.
Režen, Tadeja, et al.. (2017). Evaluation of Selected CYP51A1 Polymorphisms in View of Interactions with Substrate and Redox Partner. Frontiers in Pharmacology. 8. 417–417. 8 indexed citations
17.
Režen, Tadeja, Peter Juvan, Damjana Rozman, et al.. (2011). Obesity resistant mechanisms in the Lean polygenic mouse model as indicated by liver transcriptome and expression of selected genes in skeletal muscle. BMC Genomics. 12(1). 96–96. 15 indexed citations
18.
Juvan, Peter, et al.. (2011). The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action. Pharmacogenetics and Genomics. 21(11). 741–750. 28 indexed citations
19.
Conklin, Daniel J., Oleg A. Barski, Jean‐François Lesgards, et al.. (2009). Acrolein consumption induces systemic dyslipidemia and lipoprotein modification. Toxicology and Applied Pharmacology. 243(1). 1–12. 79 indexed citations
20.
Režen, Tadeja, Juan Antonio Rojas‐Contreras, & Damjana Rozman. (2007). Functional Genomics Approaches to Studies of the Cytochrome P450 Superfamily. Drug Metabolism Reviews. 39(2-3). 389–399. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026